Patients' experiences with generic substitution: A Swedish pharmacy survey

Journal of Pharmaceutical Health Services Research

Volumn 2, Issue 1, 2011, Pages 9-15

  Frisk, Pia ^a   Rydberg, Tony ^a,b   Carlsten, Anders ^c,d   Ekedahl, Anders ^d,e  

^a Apoteket AB   (Sweden)

^b Vårdapoteket i Norden AB   (Sweden)

^c NORDIC SCHOOL OF PUBLIC HEALTH   (Sweden)

^d MEDICAL PRODUCTS AGENCY   (Sweden)

^e LINNAEUS UNIVERSITY   (Sweden)

Author keywords

Customer survey; Generic substitution; Medication errors; Patient experiences; Pharmacy; Sweden

Indexed keywords

GENERIC DRUG;

ADULT; AGED; ARTICLE; CONSUMER ATTITUDE; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PERSONAL EXPERIENCE; PRESCRIPTION; PRIORITY JOURNAL; SWEDEN;

EID: 84860389676     PISSN: 17598885     EISSN: 17598893     Source Type: Journal    
DOI: 10.1111/j.1759-8893.2011.00036.x     Document Type: Article

References (21)

1. Swedish Pharmaceutical Benefits Board. [The Swedish Pharmaceutical Benefits Board Annual Report 2007]. Solna: The Swedish Pharmaceutical Benefits Board; 2008 [in Swedish].
2. Engström A etal. Heavy downward pressure on prices of medicines after the introduction of generic substitution. Solna: The Swedish Pharmaceutical Benefits Board; 2006 [in Swedish].
3. LIF The Research-based Pharmaceutical Industry in Sweden. Fakta 2010 - Swedish Pharmaceutical Market and Health Care. Stockholm: LIF The Research-based Pharmaceutical Industry in Sweden; 2010 [in Swedish].
4. Andersson K etal. Impact of a generic substitution reform on patients' and society's expenditure for pharmaceuticals. Health Policy 2007; 81: 376-384.
5. Nordling S etal. What Happened in the Trial with Generic Substitution in Scania? Stockholm: Swedish Academy of Pharmaceutical Sciences; 2000 [in Swedish].
6. Bergmark E etal. Patient safety with generic substitution of drugs at the pharmacy. Stockholm: The National Board of Health and Welfare; 2004 [in Swedish].
7. Heikkila R etal. Customers' and physicians' opinions of and experiences with generic substitution during the first year in Finland. Health Policy 2007; 82: 366-374.
8. Andersson K etal. Physicians' opinions and experiences of the Pharmaceutical Benefits Reform. Scand J Public Health 2006; 34: 654-659.
9. Kjoenniksen I etal. Patients' attitudes towards and experiences of generic drug substitution in Norway. Pharm World Sci 2006; 28: 284-289.
10. Andersen ML etal. How do patients evaluate the newly introduced system of substituting prescriptions? Ugeskr Laeger 2000; 162: 6066-6069 [in Danish].
11. Shrank WH etal. Patients' perceptions of generic medications. Health Aff (Millwood) 2009; 28: 546-556.
12. Himmel W etal. What do primary care patients think about generic drugs? Int J Clin Pharmacol Ther 2005; 43: 472-479.
13. Iosifescu A etal. Beliefs about generic drugs among elderly adults in hospital-based primary care practices. Patient Educ Couns 2008; 73: 377-383.
14. Palagyi M, Lassanova M. Patients attitudes towards experience with use of generics in Slovakia, performance of generic substitution. Bratisl Lek Listy 2008; 109: 324-328.
15. Ringuier R etal. Fifty years old and more patients' attitudes towards and experiences of generic substitution of prescription medicines. Therapie 2008; 63: 11-17 [in French].
16. Shrank WH etal. Patient, physician, pharmacy, and pharmacy benefit design factors related to generic medication use. J Gen Intern Med 2007; 22: 1298-1304.
17. Frisk P etal. Utilisation of angiotensin receptor blockers in Sweden: combining survey and register data to study adherence to prescribing guidelines. Eur J Clin Pharmacol 2008; 64: 1223-1229.
18. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment. 2010. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 2009.
19. Dam P, Rossing C. Revealing Customer Attitudes to and Experiences of Substitution. Evaluation Report December - 2007. Hilleröd: Pharmakon; 2007 [in Danish].
20. Madsen S etal. Pharmacy customers' attitude to generics. Tidsskr Nor Laegeforen 2003; 123: 792-793 [in Norwegian].
21. Ekedahl A. Three out of four patients have at least one noncurrent prescription and/or prescription duplicate in the EMR and the NPR. Rapport om läkemedel, Läkemedelskommittén vid Örebro läns landsting; 2010 (in press) [in Swedish].